Samsara BioCapital as of Dec. 31, 2023
Portfolio Holdings for Samsara BioCapital
Samsara BioCapital holds 41 positions in its portfolio as reported in the December 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Scholar Rock Hldg Corp (SRRK) | 19.9 | $128M | 6.8M | 18.80 | |
| Rayzebio | 17.9 | $115M | 1.8M | 62.17 | |
| Cargo Therapeutics (CRGX) | 14.8 | $95M | 4.1M | 23.15 | |
| Mineralys Therapeutics (MLYS) | 6.0 | $39M | 4.5M | 8.60 | |
| Arcellx Common Stock (ACLX) | 4.0 | $26M | 460k | 55.50 | |
| Neurogene (NGNE) | 3.8 | $25M | 1.3M | 19.38 | |
| Graphite Bio | 3.4 | $22M | 8.5M | 2.62 | |
| Nkarta (NKTX) | 2.9 | $19M | 2.9M | 6.60 | |
| Acelyrin (SLRN) | 2.9 | $19M | 2.5M | 7.46 | |
| Zymeworks Del (ZYME) | 2.4 | $15M | 1.5M | 10.39 | |
| Lyra Therapeutics (LYRA) | 2.3 | $15M | 2.8M | 5.24 | |
| Syros Pharmaceuticals Com New (SYRS) | 2.2 | $14M | 1.8M | 7.79 | |
| Avadel Pharmaceuticals Sponsored Adr (AVDL) | 2.1 | $14M | 968k | 14.12 | |
| Hillevax (HLVX) | 2.0 | $13M | 799k | 16.05 | |
| Abivax Sa Sponsored Ads (ABVX) | 1.4 | $9.1M | 850k | 10.70 | |
| Rhythm Pharmaceuticals (RYTM) | 1.2 | $7.9M | 173k | 45.97 | |
| Sutro Biopharma (STRO) | 1.1 | $7.2M | 1.7M | 4.29 | |
| Verona Pharma Sponsored Ads (VRNA) | 1.1 | $6.9M | 348k | 19.88 | |
| Io Biotech (IOBT) | 1.1 | $6.8M | 3.6M | 1.88 | |
| Inozyme Pharma (INZY) | 1.0 | $6.7M | 1.6M | 4.26 | |
| Tango Therapeutics (TNGX) | 1.0 | $6.2M | 630k | 9.90 | |
| Gossamer Bio (GOSS) | 0.9 | $5.6M | 6.1M | 0.91 | |
| Immatics SHS (IMTX) | 0.6 | $4.2M | 396k | 10.53 | |
| Prime Medicine (PRME) | 0.6 | $4.2M | 470k | 8.86 | |
| Janux Therapeutics (JANX) | 0.6 | $3.9M | 360k | 10.73 | |
| Pepgen (PEPG) | 0.5 | $3.0M | 437k | 6.80 | |
| Day One Biopharmaceuticals I (DAWN) | 0.4 | $2.9M | 196k | 14.60 | |
| Leap Therapeutics Com New (LPTX) | 0.4 | $2.8M | 669k | 4.14 | |
| Rain Therapeutics | 0.4 | $2.4M | 2.0M | 1.20 | |
| Terns Pharmaceuticals (TERN) | 0.2 | $1.3M | 202k | 6.49 | |
| Igm Biosciences (IGMS) | 0.2 | $1.3M | 155k | 8.31 | |
| Bolt Biotherapeutics (BOLT) | 0.2 | $1.2M | 1.0M | 1.12 | |
| Aclaris Therapeutics (ACRS) | 0.1 | $731k | 696k | 1.05 | |
| Vtv Therapeutics Cl A New (VTVT) | 0.1 | $470k | 41k | 11.50 | |
| Allakos (ALLK) | 0.1 | $470k | 172k | 2.73 | |
| Viracta Therapeutics (VIRX) | 0.1 | $393k | 690k | 0.57 | |
| Science 37 Holdings Com New | 0.0 | $240k | 45k | 5.34 | |
| Kronos Bio (KRON) | 0.0 | $98k | 78k | 1.25 | |
| Allovir (ALVR) | 0.0 | $56k | 82k | 0.68 | |
| Nuvation Bio *w Exp 07/07/202 (NUVB.WS) | 0.0 | $8.0k | 133k | 0.06 | |
| Surrozen *w Exp 08/01/203 (SRZNW) | 0.0 | $1.9k | 100k | 0.02 |
